A miracle for the end of 2022. In the United Kingdom, Robert Glynn learned in 2020 that he was suffering biliary tract cancer. In France, this cancer affects approximately 2,000 people each year. At the time of the announcement, the doctors tell him that he has about a year left to live.
But a new medical trial led by the Christie NHS Foundation Trust in Manchester has changed everything. This patient received an immunotherapy drug, approved for use in other forms of cancers (such as lung and kidney), combined with standard chemotherapy. Currently, this drug cannot be named due to the experimental nature of the trial. Immunotherapy works by helping the immune system recognize and attack cancer cells.
“Pre-treatment analysis of Glynn’s tumor showed that she had high mutation burden (a large number of genetic mutations in the cells), suggesting that he might have a good response to treatment. The treatment, which is given by infusion and helps a person’s own immune system fight cancer, was combined with standard chemotherapy.
A miracle
With this treatment, his liver tumor shrunk from 12cm to 2.6cm and that of his adrenal gland went from 7 cm to 4.1 cm. As a result, he was able to perform surgery…